Home › Glioblastoom

Glioblastoom klinische studies rekruteren in de VS

157 studies voor Glioblastoom rekruteren deelnemers op locaties doorheen de Verenigde Staten.

Steden met de meeste studies

• New York City, NY30 studies
• Boston, MA28 studies
• Houston, TX25 studies
• Los Angeles, CA23 studies
• Durham, NC20 studies
• San Francisco, CA17 studies
• Washington, DC15 studies
• Rochester, MN15 studies
• Chicago, IL15 studies
• Miami, FL14 studies
• Columbus, OH14 studies
• Jacksonville, FL13 studies
• Aurora, CO12 studies
• St. Louis, MO12 studies
• Atlanta, GA11 studies
• Salt Lake City, UT11 studies
• Philadelphia, PA11 studies
• Baltimore, MD11 studies
• Cleveland, OH11 studies
• Baldwin Park, CA10 studies
• Pittsburgh, PA9 studies
• Birmingham, AL9 studies
• Dallas, TX9 studies
• Nashville, TN9 studies
• Phoenix, AZ8 studies
• Winston-Salem, NC8 studies
• Seattle, WA8 studies
• San Antonio, TX8 studies
• San Diego, CA7 studies
• Edison, NJ7 studies
• Cincinnati, OH6 studies
• Tampa, FL6 studies
• Madison, WI6 studies
• Ann Arbor, MI6 studies
• Lexington, KY5 studies
• Mountain View, CA5 studies
• Queens, NY5 studies
• Omaha, NE5 studies
• Arlington, VA5 studies
• Charlottesville, VA5 studies

Per staat

• Alabama9 studies
• Arizona13 studies
• Californië40 studies
• Colorado14 studies
• Connecticut5 studies
• District of Columbia9 studies
• Florida30 studies
• Georgia12 studies
• Illinois16 studies
• Indiana4 studies
• Iowa4 studies
• Kansas3 studies
• Kentucky5 studies
• Maryland16 studies
• Massachusetts29 studies
• Michigan11 studies
• Minnesota19 studies
• Missouri12 studies
• Nebraska5 studies
• New Jersey8 studies
• New York33 studies
• North Carolina26 studies
• Ohio23 studies
• Oklahoma4 studies
• Pennsylvania21 studies
• Rhode Island3 studies
• South Carolina3 studies
• Tennessee10 studies
• Texas33 studies
• Utah11 studies
• Virginia10 studies
• Washington9 studies
• Wisconsin8 studies

Recent bijgewerkte studies

Officiële studietekst (Engels)

Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.